INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 43h ago
HOUSE PTR3h ago
SEC 13F3h ago
ROBINHOOD CHAIN3h ago
Corporate insider
FP

Foff Erin Pennock

Chief Medical OfficerCIK 0002021233

EDGAR filingsOpen in network
Disclosed transactions19
Buys / sells0 / 14
Max Insider Score39
Connections1with evidence

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
32
FP
Foff Erin PennockChief Medical Officer
MPLTMapLight Therapeutics, Inc.
Open-market sale
SELL$124K
15.4K sh
Oct 15, 2026Oct 16, 2026
traded Oct 15, 2026
+1dSEC FORM 4

Evidence

Verified connections

  • Insider ofevidence
    MapLight Therapeutics, Inc.Chief Medical Officer · Jan 29, 2026
2
FP
Foff Erin PennockChief Medical Officer
MPLTMapLight Therapeutics, Inc.
Grant or award
A
—
13.4K sh
Aug 17, 2026
Aug 19, 2026
traded Aug 17, 2026
+2d
SEC FORM 4

Evidence

2
FP
Foff Erin PennockChief Medical Officer
MPLTMapLight Therapeutics, Inc.
Grant or award
A—
54.2K sh
Aug 17, 2026Aug 19, 2026
traded Aug 17, 2026
+2dSEC FORM 4

Evidence

16
FP
Foff Erin PennockChief Medical Officer
MPLTMapLight Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$123K
4,321 sh
May 7, 2026May 11, 2026
traded May 7, 2026
+4dSEC FORM 4

Evidence

13
FP
Foff Erin PennockChief Medical Officer
MPLTMapLight Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$3,405
117 sh
May 7, 2026May 11, 2026
traded May 7, 2026
+4dSEC FORM 4

Evidence

22
FP
Foff Erin PennockChief Medical Officer
MPLTMapLight Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$252K
9,180 sh
May 4, 2026May 6, 2026
traded May 4, 2026
+2dSEC FORM 4

Evidence

13
FP
Foff Erin PennockChief Medical Officer
MPLTMapLight Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$27K
931 sh
May 5, 2026May 6, 2026
traded May 5, 2026
+1dSEC FORM 4

Evidence

19
FP
Foff Erin PennockChief Medical Officer
MPLTMapLight Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$155K
5,460 sh
May 4, 2026May 6, 2026
traded May 4, 2026
+2dSEC FORM 4

Evidence

19
FP
Foff Erin PennockChief Medical Officer
MPLTMapLight Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$463K
15.9K sh
May 6, 2026May 6, 2026
traded May 6, 2026
+0dSEC FORM 4

Evidence

16
FP
Foff Erin PennockChief Medical Officer
MPLTMapLight Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$9,223
312 sh
May 4, 2026May 6, 2026
traded May 4, 2026
+2dSEC FORM 4

Evidence

19
FP
Foff Erin PennockChief Medical Officer
MPLTMapLight Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$271K
9,645 sh
May 5, 2026May 6, 2026
traded May 5, 2026
+1dSEC FORM 4

Evidence

16
FP
Foff Erin PennockChief Medical Officer
MPLTMapLight Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$229K
8,152 sh
May 6, 2026May 6, 2026
traded May 6, 2026
+0dSEC FORM 4

Evidence

16
FP
Foff Erin PennockChief Medical Officer
MPLTMapLight Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$21K
700 sh
May 4, 2026May 6, 2026
traded May 4, 2026
+2dSEC FORM 4

Evidence

39
FP
Foff Erin PennockChief Medical Officer
MPLTMapLight Therapeutics, Inc.
Open-market sale
SELL$55K
2,044 sh
Apr 15, 2026Apr 17, 2026
traded Apr 15, 2026
+2dSEC FORM 4

Evidence

32
FP
Foff Erin PennockChief Medical Officer
MPLTMapLight Therapeutics, Inc.
Open-market sale
SELL$7,779
288 sh
Apr 16, 2026Apr 17, 2026
traded Apr 16, 2026
+1dSEC FORM 4

Evidence

32
FP
Foff Erin PennockChief Medical Officer
MPLTMapLight Therapeutics, Inc.
Open-market sale
SELL$24K
881 sh
Apr 16, 2026Apr 17, 2026
traded Apr 16, 2026
+1dSEC FORM 4

Evidence

9
FP
Foff Erin PennockChief Medical Officer
MPLTMapLight Therapeutics, Inc.
Grant or award
A—
54.2K sh
Feb 5, 2026Feb 9, 2026
traded Feb 5, 2026
+4dSEC FORM 4

Evidence

9
FP
Foff Erin PennockChief Medical Officer
MPLTMapLight Therapeutics, Inc.
Grant or award
A—
13.4K sh
Feb 5, 2026Feb 9, 2026
traded Feb 5, 2026
+4dSEC FORM 4

Evidence

19
FP
Foff Erin PennockChief Medical Officer
MPLTMapLight Therapeutics, Inc.
Tax withholding
F$802K
44.6K sh
Jan 27, 2026Jan 29, 2026
traded Jan 27, 2026
+2dSEC FORM 4

Evidence